Abstract:Drug resistance poses a serious threat to human health and agricultural production. Azole drugs are the largest group of 14-α sterol demethylation inhibitor fungicides that are used both in agriculture and in clinical practice. As plant-pathogenic molds share their natural environment with fungi that cause opportunistic infections in humans, both are exposed to a strong and persistent pressure of demethylase inhibitor (DMI) fungicides, including imidazole and triazole drugs. As a result, a loss of efficacy has occurred for this drug class in several species. In the clinical setting, Aspergillus fumigatus azole resistance is a growing public health problem, and finding the source of this resistance has gained much attention. It is urgent to determine if there is a direct link between the agricultural use of azole compounds and the different A. fumigatus resistance mechanisms described for clinical triazoles. In this study, we performed A. fumigatus susceptibility testing against clinical triazoles and crop protection DMIs using a collection of azole-susceptible and -resistant strains which harbor most of the described azole resistance mechanisms. Various DMI susceptibility profiles have been found in the different A. fumigatus population groups based on their azole resistance mechanism and previous whole-genome sequencing (WGS) analysis, which suggests that the different resistance mechanisms have different origins and are specifically associated with the local use of a particular DMI. IMPORTANCE Due to the worldwide emergence of A. fumigatus azole resistance, this opportunistic pathogen poses a serious health threat, and therefore, it has been included in the watch list in the CDC publication Antibiotic Resistance Threats in the United States, 2019 (CDC, 2019). Azoles play a critical role in the control and management of fungal diseases, not only in the clinical setting but also in agriculture. Thus, azole resistance leads to a limited therapeutic arsenal which reduces the treatment options for aspergillosis patients, increasing their mortality risk. Evidence is needed to understand whether A. fumigatus azole resistance is emerging from an agricultural source due to the extended use of demethylase inhibitors as fungicides or whether it is coming from somewhere else, such as the clinical setting. If the environmental route is demonstrated, the current use and management of azole antifungal compounds might be forced to change in the coming years.

Emergence of Triazole Resistance in Aspergillus spp. in Latin America

Antifungal resistance mechanisms of Aspergillus.

Azole‐resistant Aspergillus fumigatus as an emerging worldwide pathogen

Azole resistance in Aspergillus fumigatus: a growing public health concern

Azole resistance in a clinical isolate of Aspergillus fumigatus from Chile

Prevalence of Azole-Resistant Aspergillus fumigatus is Highly Associated with Azole Fungicide Residues in the Fields

Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina

Triazole Resistance in Aspergillus Fumigatus in Crop Plant Soil after Tebuconazole Applications.

Epidemiology and Prevalence of Azole-Resistant Aspergillus fumigatus: What Is Our Understanding of the Situation?

Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance

Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia

Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture?

Aspergillus fumigatus Cross-Resistance between Clinical and Demethylase Inhibitor Azole Drugs

Surveillance of Amphotericin B and Azole Resistance in Aspergillus Isolated from Patients in a Tertiary Teaching Hospital

(New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples

Azole resistance in Aspergillus fumigatus- comprehensive review

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Recent Advances and Future Perspectives in Mitigating Invasive Antifungal-Resistant Pathogen Aspergillus fumigatus in Africa

Antifungal Resistance in Clinical Isolates of Candida glabrata in Ibero-America

Distribution of Aspergillus species and prevalence of azole resistance in clinical and environmental samples from a Spanish hospital during a three‐year study period

Nonrandom Distribution of Azole Resistance across the Global Population of Aspergillus fumigatus